These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28766862)

  • 21. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
    Leroux AE; Krauth-Siegel RL
    Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The chemotherapy of protozoal infections of man.
    Steck EA
    J Protozool; 1981 Feb; 28(1):10-6. PubMed ID: 6788942
    [No Abstract]   [Full Text] [Related]  

  • 23. Identification and functional characterization of Trypanosoma brucei peroxin 16.
    Kalel VC; Schliebs W; Erdmann R
    Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2326-37. PubMed ID: 26025675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteasome as a Drug Target in Trypanosomatid Diseases.
    Silva ML; de Santiago-Silva KM; Fabris M; Camargo PG; de Lima Ferreira Bispo M
    Curr Drug Targets; 2023; 24(10):781-789. PubMed ID: 37469152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of novel drugs for human African trypanosomiasis.
    Brun R; Don R; Jacobs RT; Wang MZ; Barrett MP
    Future Microbiol; 2011 Jun; 6(6):677-91. PubMed ID: 21707314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis.
    World Health Organization
    World Health Organ Tech Rep Ser; 2012; (975):v-xii, 1-100. PubMed ID: 23484340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
    González M; Cerecetto H
    Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alkaloids with antiprotozoal activity.
    Osorio EJ; Robledo SM; Bastida J
    Alkaloids Chem Biol; 2008; 66():113-90. PubMed ID: 19025098
    [No Abstract]   [Full Text] [Related]  

  • 29. Progresses in the field of drug design to combat tropical protozoan parasitic diseases.
    Liñares GE; Ravaschino EL; Rodriguez JB
    Curr Med Chem; 2006; 13(3):335-60. PubMed ID: 16475941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclic nucleotide signaling mechanisms in trypanosomes: possible targets for therapeutic agents.
    Laxman S; Beavo JA
    Mol Interv; 2007 Aug; 7(4):203-15. PubMed ID: 17827441
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secreted proteases of Trypanosoma brucei gambiense: possible targets for sleeping sickness control?
    Bossard G; Cuny G; Geiger A
    Biofactors; 2013; 39(4):407-14. PubMed ID: 23553721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organometallic compounds in the discovery of new agents against kinetoplastid-caused diseases.
    Ravera M; Moreno-Viguri E; Paucar R; Pérez-Silanes S; Gabano E
    Eur J Med Chem; 2018 Jul; 155():459-482. PubMed ID: 29908440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria.
    Scarim CB; Jornada DH; Machado MGM; Ferreira CMR; Dos Santos JL; Chung MC
    Eur J Med Chem; 2019 Jan; 162():378-395. PubMed ID: 30453246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination therapy for sleeping sickness: a wake-up call.
    Pepin J
    J Infect Dis; 2007 Feb; 195(3):311-3. PubMed ID: 17205466
    [No Abstract]   [Full Text] [Related]  

  • 35. Leishmaniasis and Chagas Disease - Neglected Tropical Diseases: Treatment Updates.
    Sangenito LS; da Silva Santos V; d'Avila-Levy CM; Branquinha MH; Souza Dos Santos AL; de Oliveira SSC
    Curr Top Med Chem; 2019; 19(3):174-177. PubMed ID: 30950334
    [No Abstract]   [Full Text] [Related]  

  • 36. Biological evaluation and structure-activity relationships of imidazole-based compounds as antiprotozoal agents.
    Saccoliti F; Madia VN; Tudino V; De Leo A; Pescatori L; Messore A; De Vita D; Scipione L; Brun R; Kaiser M; Mäser P; Calvet CM; Jennings GK; Podust LM; Costi R; Di Santo R
    Eur J Med Chem; 2018 Aug; 156():53-60. PubMed ID: 30006174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.
    Cheuka PM; Mayoka G; Mutai P; Chibale K
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28042865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parasite Polyamines as Pharmaceutical Targets.
    Roberts S; Ullman B
    Curr Pharm Des; 2017; 23(23):3325-3341. PubMed ID: 28571553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Amazing World of Peptide Engineering: the Example of Antimicrobial Peptides from Frogs and Their Analogues.
    Guimarães AB; Costa FJ; Pires OR; Fontes W; Castro MS
    Protein Pept Lett; 2016; 23(8):722-37. PubMed ID: 27262306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness.
    Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.